Follow The ‘Science’

Homepage | Forums | Main Forums | Multimedia | Follow The ‘Science’

Viewing 2 reply threads
  • Author
    Posts
    • #428337
      Yanath
      Participant
      • Total Posts: 1,902
    • #428350
      lownslow
      Participant
      • Total Posts: 652

      Wow! Scams on top of scams! To me this is more reasons to be sceptical of the vaccines, that new alzheimers drug, etc. Great find!

      • #428405
        Yanath
        Participant
        • Total Posts: 1,902

        I remember when my mother had to stop taking one of those statins that were removed from the market, for which doctors were receiving incentives like vacations from drug companies to prescribe. Fortunately, it only caused a permanent ringing in her ears. Clearly the scams have grown in sophistication by orders of magnitude.

    • #428363
      soryang
      Participant
      • Total Posts: 1,271

      Aduhelm (aducanumab) it has to be taken intravenously, which means it is administered in an appropriate clinical setting. Cost of treatment and monitoring estimated at 56 thousand dollars a year. Is it effective? Maybe, maybe not. It was approved on an “accelerated pathway” by the FDA in spite of the disagreement of the advisory committee.

      We know that the Peripheral and Central Nervous System Drugs Advisory Committee, which convened in November 2020 to review the clinical trial data and discuss the evidence supporting the Aduhelm application, did not agree that it was reasonable to consider the clinical benefit of the one successful trial as the primary evidence supporting approval. The option of Accelerated Approval was not discussed by the Advisory Committee.

      https://www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease

      In my opinion Alzheimer’s patients have difficulty getting inexpensive generic drugs to help relieve symptoms, because they can be habit forming and lead to dependency. In the opinion of some providers, these drugs, actually may have a beneficial impact on the progression of the disease. On the other hand, all the stops are removed despite unknown risks and conjectural benefits for a new treatment, which presents the prospect of huge profits for the applicant.

Viewing 2 reply threads
  • You must be logged in to reply to this topic.